PCVX250117P65000
- 2.21
- 0.000.00%
Vaxcyte Newsroom
US Stock Digging for Gold | Meta Makes Concessions Under EU Antitrust! eBay Soars Nearly 10% Overnight; Henry Hub Natural Gas Stocks Make a Comeback in the New Year! Stocks like EQT Corp Continue to Rise.
Milestone development! Streaming company Roku revealed that in the first week of 2025, it gained 90 million household users, and the stock price has risen over 11% within five trading days this year.
Sling Therapeutics Appoints Andrew Guggenhime to Its Board of Directors
U.S. stocks gold mining | Apple's stock price hits new highs consecutively! Sprinting towards a 4 trillion dollar Market Cap; AI Technology stocks continue to be strong, with Palantir and "little NVIDIA" Astera Labs both reaching new highs.
AI technology stocks continue to thrive, with stock prices reaching new highs! Palantir and "little NVIDIA" Astera Labs also hit new records; Apple has reached an all-time high! The total market value has reached 3.9 trillion USD, approaching the 4 trillion USD mark.
Goldman Sachs Initiates Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $135
Goldman Sachs Initiates Coverage On Vaxcyte With Buy Rating, Announces Price Target of $135
Vaxcyte Analyst Ratings
Vaxcyte Insider Sold Shares Worth $710,249, According to a Recent SEC Filing
We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate
Vaxcyte: Promising Developments and Strategic Advancements Boost Confidence in Stock Potential
Vaxcyte Doses First Subject in Pneumococcal Conjugate Vaccine Trial in Infants
Express News | Vaxcyte Inc - on Track to Announce Vax-24 Phase 2 Infant Study Data by Q1 2025
Express News | Vaxcyte Initiates Phase 2 Study Evaluating Vax-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
(PCVX) - Analyzing Vaxcyte's Short Interest
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus
Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
"Anti-vaccine pioneer" nominated by Trump as Secretary of Health, vaccine stocks plummeted.
Trump nominated Robert F. Kennedy Jr. to be the Secretary of Health. Kennedy holds many unorthodox views in the field of public health, the most famous of which is questioning the safety and effectiveness of vaccines. He referred to vaccine injections as "crimes against humanity" during the COVID-19 pandemic and likened it to the Nazi Holocaust.